| Ms Monica Lynde Ciolino, DPT | |
|
1 Progress Point Pkwy, Ste 100, O Fallon, MO 63368-2211 | |
| (314) 286-1940 | |
| (314) 747-7044 |
| Full Name | Ms Monica Lynde Ciolino |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 1 Progress Point Pkwy, O Fallon, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023623329 | NPI | - | NPPES |
| 480089113 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2020029936 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
A novel avian-origin reassortant influenza A (H7N9) virus emerged in China in February 2013, and is associated with severe lower respiratory tract diseases. To date, more than 100 human cases of infection, including at least 20 deaths, have been reported in China.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
For up-to-date information about lung cancer, you can contact the Thomas G. Labrecque Foundation. The foundation was founded in 2002 by the Labrecque family in honor of Tom Labrecque, former chairman of the Chase Manhattan Bank. Mr. Labrecque, a non-smoker, died of lung cancer.
The antiplatelet drug cilostazol — used in the United States to treat leg pain associated with peripheral vascular disease — was more effective and safer than aspirin at preventing recurrent strokes in a Japanese trial presented as late-breaking science at the American Stroke Association's International Stroke Conference 2010.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,795,302 entitled "Use of Compositions for Treating Rosacea."
› Verified 2 days ago
| Provider Name | Washington University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922048420 PECOS PAC ID: 9830008770 Enrollment ID: O20040226000756 |
News Archive
A novel avian-origin reassortant influenza A (H7N9) virus emerged in China in February 2013, and is associated with severe lower respiratory tract diseases. To date, more than 100 human cases of infection, including at least 20 deaths, have been reported in China.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
For up-to-date information about lung cancer, you can contact the Thomas G. Labrecque Foundation. The foundation was founded in 2002 by the Labrecque family in honor of Tom Labrecque, former chairman of the Chase Manhattan Bank. Mr. Labrecque, a non-smoker, died of lung cancer.
The antiplatelet drug cilostazol — used in the United States to treat leg pain associated with peripheral vascular disease — was more effective and safer than aspirin at preventing recurrent strokes in a Japanese trial presented as late-breaking science at the American Stroke Association's International Stroke Conference 2010.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,795,302 entitled "Use of Compositions for Treating Rosacea."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Monica Lynde Ciolino, DPT Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 286-1940 | Ms Monica Lynde Ciolino, DPT 1 Progress Point Pkwy, Ste 100, O Fallon, MO 63368-2211 Ph: (314) 286-1940 |
News Archive
A novel avian-origin reassortant influenza A (H7N9) virus emerged in China in February 2013, and is associated with severe lower respiratory tract diseases. To date, more than 100 human cases of infection, including at least 20 deaths, have been reported in China.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
For up-to-date information about lung cancer, you can contact the Thomas G. Labrecque Foundation. The foundation was founded in 2002 by the Labrecque family in honor of Tom Labrecque, former chairman of the Chase Manhattan Bank. Mr. Labrecque, a non-smoker, died of lung cancer.
The antiplatelet drug cilostazol — used in the United States to treat leg pain associated with peripheral vascular disease — was more effective and safer than aspirin at preventing recurrent strokes in a Japanese trial presented as late-breaking science at the American Stroke Association's International Stroke Conference 2010.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,795,302 entitled "Use of Compositions for Treating Rosacea."
› Verified 2 days ago
Athletico Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 343 Winding Woods Ctr, O Fallon, MO 63366 Phone: 636-439-2004 Fax: 636-439-2054 | |
Jennifer Jo Freeling, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3404 E Terra Ln, O Fallon, MO 63366 Phone: 636-970-0336 Fax: 636-970-0337 | |
Ms. Kathryn R Summers, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 939 Highway K, O Fallon, MO 63366 Phone: 636-240-7000 Fax: 636-240-7513 | |
Lorenzo G Catapang, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 343 Winding Woods Ctr, O Fallon, MO 63366 Phone: 636-439-2004 Fax: 636-439-2054 | |
Caitlin M Niemeier, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1096 Tom Ginnever Ave, O Fallon, MO 63366 Phone: 636-978-5255 Fax: 636-978-5287 | |
Mr. Richard Sebastian Pagano, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1601 E Terra Ln, O Fallon, MO 63366 Phone: 636-978-6634 | |
Stephanie Ward, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 951 Waterbury Falls Dr, O Fallon, MO 63368 Phone: 636-336-0300 Fax: 636-336-0297 |